Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
OrganXpert
2025

Share:

OrganXpert

Clinical Trial Alternative Cell Culture Platform

OrganXpert significantly advances medical development by overcoming traditional clinical trial limitations and presenting a new paradigm. It enables direct experimentation on selectively cultured human cells, aiming to replace clinical trials. The OrganXpert creates an optimal environment for stem cells, supported by surrounding products. It can culture 12 cell culture chips simultaneously, making it fast and economical. The integrated recirculating flow module mimics human fluid flow, allowing for tissue modeling. The design focuses on usability, featuring a one-touch cartridge detachment and a simplified interface for intuitive operation.

Client / Manufacturer

Biospero

Jeju island, KR
Design
Via Collective

Via Collective

Seoul, KRHankak Lee, Seungsu Mok, Hayoung Lee
Date of Launch
2025
Development Time
up to 24 Month
Target Regions
North America
Target Groups
"University / University Hospital / Laboratory / Pharmaceutical Company / CRO"

RELATED PROJECTS